To probe how WDR26 regulates GPCR signaling in breast cancers, we examined the effect of WDR26 downregulation on the activation of Gα- or Gβγ-mediated signaling pathways downstream of GPCR stimulation. Here, WDR26 is linked to breast carcinoma.